WEBINAR
Recording: Closing the Gaps in Multiple Myeloma with Data and AI
Despite significant advancements in treatment over the past decade, the 5-year survival of multiple myeloma stands at 58% for all SEER stages. We believe that a deeper understanding of both patients and the comparative effectiveness of treatments, alongside novel drugs, is essential for improving outcomes in this complex disease.
Join real-world experts at TriNetX and Databricks as we examine how rich and timely clinical data, unified in a research-ready environment, can provide clinical researchers with the best opportunity to accelerate time-to-insight and influence outcomes.
Agenda:
- Multiple Myeloma: Progress Made, Progress Needed
Luis Arthur Flores Pelloso MD, PhD, Executive Medical Director, TA Lead for HemOnc, PPD, part of Thermo Fisher Scientific - Deep Data for a Complex Disease
Jeff Graham, Vice President Real-World Data & Innovation, TriNetX - Scaling Success with the Right Data and Technology
Michael Sanky, Global Industry Lead, Healthcare & Life Sciences, Databricks
What’s inside:
- Explore a recent success in sourcing, curating, and inferring key scores from this data, based on 100,000 de-identified U.S. patients diagnosed since 2010.
- Showcase how organizations can de-identify, gather and harmonize millions of treatment-related observations.
- Demonstrate how to organize data in carefully documented, analysis-ready tables using the power of Databricks Lakehouse.
- Examine how clinical expertise, machine learning experience, and best-in-class technology can converge to better understand disease progression (measured by ECOG scores) for thousands of patients, enabling outcome-oriented evidence generated at scale.
- Present lessons learned applicable to a wide array of clinical data curation and evidence generation projects.
“Are you a software company? A data company? A consulting company?”
Yes, yes, and yes. To put it simply, we’re an answer company. TriNetX is committed to helping you unearth insights that will lead to better patient care and treatment options. How you get there depends on your challenge. Need a fast, reliable answer to an incidence or prevalence question? Turn to our platform-based analytics. Want to understand the patient journey, from changing creatinine levels to cost of care? Our linked EHR and claims dataset has what you need. Ready to collaborate with the sharpest minds in real-world data? Our consulting team can’t wait to join forces with you.
Going Beyond What's Possible
As a global force, TriNetX continues to navigate uncharted territories with an unwavering commitment to revolutionizing the healthcare ecosystem.
Far beyond being a repository of information, TriNetX serves as a strategic partner in connecting health systems, providers, and researchers worldwide through our extensive real-world patient data that runs a mile wide and a mile deep.
From trial operations to evidence generation, we put you at the forefront of discovery.
Clinical Trial Design & Optimization
Data Sets & Analytics
Non-US Oncology
Real-World Evidence Generation
Pharmacovigilance & Drug Safety